# Phage Therapy in Prosthetic Joint Infection Due to Staphylococcus Aureus Treated With DAIR.

> **NCT05369104** · PHASE2 · UNKNOWN · sponsor: **Phagenix** · enrollment: 64 (estimated)

## Conditions studied

- Infection of Total Hip Joint Prosthesis
- Infection of Total Knee Joint Prosthesis

## Interventions

- **BIOLOGICAL:** Anti-Staphylococcus aureus Bacteriophages

## Key facts

- **NCT ID:** NCT05369104
- **Lead sponsor:** Phagenix
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-15
- **Primary completion:** 2023-12-16
- **Final completion:** 2025-06-16
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2022-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05369104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05369104, "Phage Therapy in Prosthetic Joint Infection Due to Staphylococcus Aureus Treated With DAIR.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05369104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*